Clinical trial
The Antidepressant Efficacy of the Anticholinergic Scopolamine
NCT00369915 · National Institute of Mental Health (NIMH), NIH · Terminated
Key facts
| NCT number | NCT00369915 |
|---|---|
| Title | The Antidepressant Efficacy of the Anticholinergic Scopolamine |
| Official title | The Antidepressant Efficacy of the Anticholinergic Scopolamine |
| Lead sponsor | National Institute of Mental Health (NIMH), NIH |
| Status | Terminated |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Unipolar Depression, Bipolar Depression |
| Intervention type | Drug |
| Interventions | Scopolamine |
| Enrollment | 17 |
| Start date | Aug 1, 2006 |
| Primary completion | Jan 1, 2013 |
| Completion | Jan 1, 2013 |
| First posted | Aug 30, 2006 |
| Last update posted | Nov 10, 2016 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: